Loading...

Ergis

WSE:EGS
Snowflake Description

Adequate balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
EGS
WSE
PLN93M
Market Cap
  1. Home
  2. PL
  3. Materials
Company description

Ergis S.A. manufactures and sells plastic packing products in Poland and internationally. The last earnings update was 99 days ago. More info.


Add to Portfolio Compare Print
  • Ergis has significant price volatility in the past 3 months.
EGS Share Price and Events
7 Day Returns
-0.4%
WSE:EGS
0.9%
PL Chemicals
-1.6%
PL Market
1 Year Returns
-45.7%
WSE:EGS
-24%
PL Chemicals
-8%
PL Market
EGS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Ergis (EGS) -0.4% -2.8% -16.3% -45.7% -40% -42%
PL Chemicals 0.9% 14.2% 32.8% -24% -40.3% -16.2%
PL Market -1.6% 0.4% 7.1% -8% 16.9% -6.4%
1 Year Return vs Industry and Market
  • EGS underperformed the Chemicals industry which returned -24% over the past year.
  • EGS underperformed the Market in Poland which returned -8% over the past year.
Price Volatility
EGS
Industry
5yr Volatility vs Market

EGS Value

 Is Ergis undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Ergis to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Ergis.

WSE:EGS Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 11.3%
Perpetual Growth Rate 10-Year PL Government Bond Rate 2.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for WSE:EGS
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year PL Govt Bond Rate 2.9%
Equity Risk Premium S&P Global 7.2%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.47
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.475 (1 + (1- 19%) (185.18%))
1.187
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.19
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.85% + (1.187 * 7.15%)
11.34%

Discounted Cash Flow Calculation for WSE:EGS using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Ergis is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

WSE:EGS DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (PLN, Millions) 4.72 4.87 5.02 5.17 5.33
Source Est @ 3.07% Est @ 3.07% Est @ 3.07% Est @ 3.07% Est @ 3.07%
Present Value
Discounted (@ 11.34%)
4.24 3.93 3.63 3.36 3.11
Present value of next 5 years cash flows PLN18.28
WSE:EGS DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= PLN5.33 × (1 + 2.85%) ÷ (11.34% – 2.85%)
PLN64.57
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= PLN64.57 ÷ (1 + 11.34%)5
PLN37.75
WSE:EGS Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= PLN18.28 + PLN37.75
PLN56.02
Equity Value per Share
(PLN)
= Total value / Shares Outstanding
= PLN56.02 / 37.89
PLN1.48
WSE:EGS Discount to Share Price
Calculation Result
Value per share (PLN) From above. PLN1.48
Current discount Discount to share price of PLN2.46
= -1 x (PLN2.46 - PLN1.48) / PLN1.48
-66.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Ergis is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Ergis's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Ergis's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
WSE:EGS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-09-30) in PLN PLN0.40
WSE:EGS Share Price ** WSE (2019-02-15) in PLN PLN2.46
Poland Chemicals Industry PE Ratio Median Figure of 12 Publicly-Listed Chemicals Companies 12.73x
Poland Market PE Ratio Median Figure of 449 Publicly-Listed Companies 10.25x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Ergis.

WSE:EGS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= WSE:EGS Share Price ÷ EPS (both in PLN)

= 2.46 ÷ 0.40

6.19x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ergis is good value based on earnings compared to the PL Chemicals industry average.
  • Ergis is good value based on earnings compared to the Poland market.
Price based on expected Growth
Does Ergis's expected growth come at a high price?
Raw Data
WSE:EGS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 6.19x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
-0.3%per year
Europe Chemicals Industry PEG Ratio Median Figure of 61 Publicly-Listed Chemicals Companies 2.01x
Poland Market PEG Ratio Median Figure of 100 Publicly-Listed Companies 1.09x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Ergis, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Ergis's assets?
Raw Data
WSE:EGS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-09-30) in PLN PLN5.69
WSE:EGS Share Price * WSE (2019-02-15) in PLN PLN2.46
Poland Chemicals Industry PB Ratio Median Figure of 17 Publicly-Listed Chemicals Companies 0.66x
Poland Market PB Ratio Median Figure of 690 Publicly-Listed Companies 1.02x
WSE:EGS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= WSE:EGS Share Price ÷ Book Value per Share (both in PLN)

= 2.46 ÷ 5.69

0.43x

* Primary Listing of Ergis.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ergis is good value based on assets compared to the PL Chemicals industry average.
X
Value checks
We assess Ergis's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Ergis has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

EGS Future Performance

 How is Ergis expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

  • No analysts cover Ergis, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-0.3%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Ergis expected to grow at an attractive rate?
  • Ergis's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.9%.
Growth vs Market Checks
  • Ergis's earnings are expected to decrease over the next 1-3 years, this is below the Poland market average.
  • Ergis's revenue growth is positive but not above the Poland market average.
Annual Growth Rates Comparison
Raw Data
WSE:EGS Future Growth Rates Data Sources
Data Point Source Value (per year)
WSE:EGS Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts -0.3%
WSE:EGS Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 4.1%
Poland Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 11.4%
Poland Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 4.9%
Poland Market Earnings Growth Rate Market Cap Weighted Average 10.1%
Poland Market Revenue Growth Rate Market Cap Weighted Average 6.4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
WSE:EGS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in PLN Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
WSE:EGS Future Estimates Data
Date (Data in PLN Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 843 1
2019-12-31 819 1
2018-12-31 780 1
WSE:EGS Past Financials Data
Date (Data in PLN Millions) Revenue Cash Flow Net Income *
2018-09-30 769 46 15
2018-06-30 777 83 16
2018-03-31 757 32 18
2017-12-31 750 26 21
2017-09-30 740 47 24
2017-06-30 719 51 26
2017-03-31 706 59 25
2016-12-31 696 29 24
2016-09-30 694 57 -17
2016-06-30 680 26 -22
2016-03-31 683 25 -17
2015-12-31 675 39 -16

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Ergis's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
  • Ergis's revenue is expected to grow by 4.1% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
WSE:EGS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (4 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Ergis Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WSE:EGS Future Estimates Data
Date (Data in PLN Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31
2019-12-31
2018-12-31
WSE:EGS Past Financials Data
Date (Data in PLN Millions) EPS *
2018-09-30 0.40
2018-06-30 0.43
2018-03-31 0.46
2017-12-31 0.54
2017-09-30 0.61
2017-06-30 0.66
2017-03-31 0.65
2016-12-31 0.61
2016-09-30 -0.43
2016-06-30 -0.55
2016-03-31 -0.43
2015-12-31 -0.41

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Ergis will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Ergis's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Poland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Poland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Ergis has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

EGS Past Performance

  How has Ergis performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Ergis's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Ergis's year on year earnings growth rate has been positive over the past 5 years.
  • Ergis's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Ergis's 1-year earnings growth is negative, it can't be compared to the PL Chemicals industry average.
Earnings and Revenue History
Ergis's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Ergis Company Filings, last reported 4 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

WSE:EGS Past Revenue, Cash Flow and Net Income Data
Date (Data in PLN Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-09-30 769.06 15.16 86.96
2018-06-30 777.33 16.30 87.09
2018-03-31 757.37 17.55 84.41
2017-12-31 749.56 20.75 83.18
2017-09-30 739.51 23.52 83.17
2017-06-30 718.64 25.74 80.06
2017-03-31 706.38 25.21 79.30
2016-12-31 695.56 23.75 77.59
2016-09-30 694.39 -16.92 75.33
2016-06-30 680.05 -21.85 75.23
2016-03-31 682.69 -17.08 75.28
2015-12-31 675.10 -16.20 75.52
2015-09-30 673.70 23.26 74.92
2015-06-30 677.26 26.45 74.61
2015-03-31 668.61 20.91 74.81
2014-12-31 667.53 19.03 74.43
2014-09-30 658.50 19.78 74.24
2014-06-30 670.62 22.17 76.36
2014-03-31 675.02 14.86 70.97
2013-12-31 673.26 11.38 71.04
2013-09-30 669.53 9.30 69.72
2013-06-30 659.39 6.42 66.09
2013-03-31 638.46 6.24 69.20
2012-12-31 633.07 7.36 67.58
2012-09-30 631.61 -22.04 67.07
2012-06-30 621.36 -29.55 66.22
2012-03-31 624.60 -25.78 64.90

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Ergis has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Ergis used its assets more efficiently than the PL Chemicals industry average last year based on Return on Assets.
  • Ergis's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Ergis's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Ergis has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

EGS Health

 How is Ergis's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Ergis's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Ergis is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Ergis's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Ergis's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Ergis Company Filings, last reported 4 months ago.

WSE:EGS Past Debt and Equity Data
Date (Data in PLN Millions) Total Equity Total Debt Cash & Short Term Investments
2018-09-30 216.06 172.62 4.17
2018-06-30 213.13 153.18 24.67
2018-03-31 214.31 198.11 17.45
2017-12-31 209.48 184.69 21.69
2017-09-30 217.74 166.69 6.21
2017-06-30 212.85 162.94 10.95
2017-03-31 214.13 162.66 7.86
2016-12-31 200.49 141.74 9.22
2016-09-30 207.25 157.84 7.46
2016-06-30 202.18 161.38 6.75
2016-03-31 200.95 168.40 6.20
2015-12-31 193.98 142.88 15.74
2015-09-30 232.06 183.28 2.90
2015-06-30 229.59 159.88 7.37
2015-03-31 222.59 169.96 16.52
2014-12-31 216.47 141.90 12.19
2014-09-30 214.22 168.25 2.06
2014-06-30 212.68 151.49 10.18
2014-03-31 206.36 172.40 4.24
2013-12-31 200.18 142.18 28.28
2013-09-30 188.99 124.37 4.52
2013-06-30 182.17 100.75 7.42
2013-03-31 181.33 135.04 3.08
2012-12-31 178.02 98.41 18.79
2012-09-30 178.09 139.18 2.87
2012-06-30 174.44 114.30 11.55
2012-03-31 174.79 133.95 4.35
  • Ergis's level of debt (79.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (65.9% vs 79.9% today).
  • Debt is well covered by operating cash flow (26.8%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 4.2x coverage).
X
Financial health checks
We assess Ergis's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Ergis has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

EGS Dividends

 What is Ergis's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
8.13%
Current annual income from Ergis dividends.
If you bought PLN2,000 of Ergis shares you are expected to receive PLN163 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Ergis's pays a higher dividend yield than the bottom 25% of dividend payers in Poland (2.53%).
  • Ergis's dividend is above the markets top 25% of dividend payers in Poland (7.75%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
WSE:EGS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Poland Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 6.3%
Poland Market Average Dividend Yield Market Cap Weighted Average of 209 Stocks 3.3%
Poland Minimum Threshold Dividend Yield 10th Percentile 1.4%
Poland Bottom 25% Dividend Yield 25th Percentile 2.5%
Poland Top 25% Dividend Yield 75th Percentile 7.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

WSE:EGS Future Dividends Estimate Data
Date (Data in PLN) Dividend per Share (annual) Avg. No. Analysts
2020-12-31
2019-12-31
2018-12-31
WSE:EGS Past Annualized Dividends Data
Date (Data in PLN) Dividend per share (annual) Avg. Yield (%)
2018-05-15 0.200 6.180
2018-04-20 0.200 4.997
2018-01-23 0.200 4.598
2017-05-17 0.200 3.471
2017-04-25 0.200 3.113
2016-02-15 0.160 3.117
2015-05-13 0.150 3.042
2015-04-30 0.150 2.867
2015-02-10 0.150 3.075
2014-04-25 0.100 2.359
2014-02-20 0.100 2.644

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, Ergis has been paying a dividend for less than 10 years.
  • Dividend payments have increased, but Ergis only paid a dividend in the past 5 years.
Current Payout to shareholders
What portion of Ergis's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (2x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Ergis's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.4%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Ergis afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Ergis has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

EGS Management

 What is the CEO of Ergis's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Tadeusz Nowicki
COMPENSATION PLN0
AGE 60
TENURE AS CEO 12.1 years
CEO Bio

Mr. Tadeusz Nowicki has been President of Management Board at Erigs S.A. since January 22, 2007 and serves as its Member of the Management Board. Mr. Nowicki has been Chief Executive Officer of ERG-W?brze?no since January 1998. He served as Head of the R&D Department of Clal. He served as the President of Ergis S.A. He was co-organizer of the merger with the American ENGELHARD, resulting in the establishment of Engelhard-Clal, the world's largest group processing gold, platinum and silver. He served as Technical Director of the Engelhard-Clal Platinum Division, assuming responsibility for three plants located in Paris, London and Amsterdam. He serves as the Chairman of the Supervisory Board at MKF-Folien GmbH. He Graduated from the Warsaw University of Technology. Mr. Nowicki awarded a PhD degree at Ecole Nationale Superieure des Mines (Saint-Etienne, France, 1988).

CEO Compensation
  • Insufficient data for Tadeusz to compare compensation growth.
  • Tadeusz's remuneration is lower than average for companies of similar size in Poland.
Management Team

Tadeusz Nowicki

TITLE
President of the Management of Board
AGE
60
TENURE
12.1 yrs

Pawel Kaczorowski

TITLE
Secretary & Member of the Supervisory Board
AGE
48
TENURE
4.7 yrs

Marek Kaplucha

TITLE
Vice-President of the Management Board
Board of Directors Tenure

Average tenure and age of the Ergis board of directors in years:

4.7
Average Tenure
57
Average Age
  • The tenure for the Ergis board of directors is about average.
Board of Directors

Marek Górski

TITLE
Chairman of the Supervisor Board
AGE
52
TENURE
4.7 yrs

Maciej Grelowski

TITLE
Vice-Chairman of the Supervisory Board
AGE
68
TENURE
4.7 yrs

Pawel Kaczorowski

TITLE
Secretary & Member of the Supervisory Board
AGE
48

Waldemar Maj

TITLE
Independent Member of the Supervisory Board
AGE
62
TENURE
4.7 yrs

Katarzyna Górska-Bednarska

TITLE
Member of Supervisory Board
TENURE
4.7 yrs

Tadeusz Iwanowski

TITLE
Independent Member of The Supervisory Board
TENURE
4.7 yrs

Maciej Stanczuk

TITLE
Independent Member of the Supervisory Board
AGE
57
TENURE
4.7 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (PLN) Value (PLN)
X
Management checks
We assess Ergis's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Ergis has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

EGS News

Simply Wall St News

Is Ergis S.A.'s (WSE:EGS) Balance Sheet Strong Enough To Weather A Storm?

Help shape the future of investing tools and you could win a $250 gift card! … (WSE:EGS) with its market cap of zł99m, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn.

Simply Wall St -

Should Ergis S.A. (WSE:EGS) Be Part Of Your Dividend Portfolio?

A large part of investment returns can be generated by dividend-paying stock given their role in compounding returns over time. … View our latest analysis for Ergis? … Take the survey and be part of one of the most advanced studies of stock market investors to date

Simply Wall St -

Does Ergis S.A.'s (WSE:EGS) P/E Ratio Signal A Buying Opportunity?

The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). … We'll show how you can use Ergis S.A.'s (WSE:EGS) P/E ratio to inform your assessment of the investment opportunity. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

Ergis SA (WSE:EGS): Assessing Capital Returns

As a result, your investment is being put to work to fund operations and if you want to earn an attractive return on your investment, the business needs to be making an adequate amount of money from the funds you provide. … You need to pay attention to this because your return on investment is linked to dividends and internal investments to improve the business, which can only occur if the company is expected to produce adequate earnings with the capital that has been provided. … To understand Ergis’s capital returns we will look at a useful metric called return on capital employed.

Simply Wall St -

Could The Ergis SA (WSE:EGS) Ownership Structure Tell Us Something Useful?

The big shareholder groups in Ergis SA (WSE:EGS) have power over the company. … Ergis is not a large company by global standards. … Our analysis of the ownership of the company, below, shows that.

Simply Wall St -

Is Ergis SA's (WSE:EGS) Balance Sheet Strong Enough To Weather A Storm?

While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they end up ignoring a key aspect, which could be the biggest threat to its existence: its financial health. … Assessing first and foremost the financial health is. … Here are a few basic checks that are good enough to have a broad overview of the company’s financial strength.

Simply Wall St -

Understanding Your Return On Investment In Ergis SA (WSE:EGS)

and want to begin learning the link between Ergis SA (WSE:EGS)’s return fundamentals and stock market performance. … Your equity share is granted in return for the capital provided to the business to operate, and in order for an investment to be successful the business has to create earnings from the funds that make up this capital. … Therefore, looking at how efficiently Ergis is able to use capital to create earnings will help us understand your potential return.

Simply Wall St -

Who Owns Ergis SA (WSE:EGS)?

In this article, I will take a quick look at Ergis SA’s (WSE:EGS) recent ownership structure – an unconventional investing subject, but an important one. … When it comes to ownership structure of a company, the impact has been observed in both the long-and short-term performance of shares. … The implications of these institutions’ actions can either benefit or hinder individual investors, so it is important to understand the ownership composition of your stock investment.

Simply Wall St -

Is Buying Ergis SA (WSE:EGS) For Its Upcoming zł0.20 Dividend A Good Choice?

If you are interested in cashing in on Ergis SA's (WSE:EGS) upcoming dividend of zł0.20 per share, you only have 2 days left to buy the shares before its ex-dividend date, 06 July 2018, in time for dividends payable on the 16 July 2018. … Is this future income stream a compelling catalyst for dividend investors to think about the stock as an investment today? … How I analyze a dividend stock

Simply Wall St -

Is Ergis SA (WSE:EGS) A Sell At Its Current PE Ratio?

But should the relatively competitive multiple be the final verdict of EGS’s undervaluation. … This is because multiples like PE tend to overlook key company-specific factors such as future growth and capital structure … To resolve this problem, I’ll identify some important factors to consider when judging the relative valuation of

Simply Wall St -

EGS Company Info

Map
Description

Ergis S.A. manufactures and sells plastic packing products in Poland and internationally. The company offers packaging for food products, such as films, PVC and PET-based barrier laminates, and printed multilayer laminates; industrial packaging products, including LLDPE stretch films and PET films; and films for packaging pharmaceuticals, hydro-insulating films, and PVC compounds. It also manufactures PET tapes, thermo-shrink PVC films, soft PVC films, and other products, as well as distributes BOPP films. In addition, Ergis S.A. provides accounting, human resources, and payroll services, as well as transportation services. Further, the company engages in plastics recycling activities. The company was formerly known as Ergis-Eurofilms S.A. and changed its name to Ergis S.A. in July 2014. Ergis S.A. is based in Warsaw, Poland.

Details
Name: Ergis S.A.
EGS
Exchange: WSE
Founded:
PLN93,214,994
37,892,274
Website: http://www.ergis-eurofilms.eu
Address: Ergis S.A.
ul. Tamka 16,
Warsaw,
00-349,
Poland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
WSE EGS Common Bearer Shares Warsaw Stock Exchange PL PLN 12. Jun 2006
LSE 0O3E Common Bearer Shares London Stock Exchange GB PLN 12. Jun 2006
Number of employees
Current staff
Staff numbers
0
Ergis employees.
Industry
Commodity Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/02/15 21:16
End of day share price update: 2019/02/15 00:00
Last estimates confirmation: 2019/02/06
Last earnings filing: 2018/11/08
Last earnings reported: 2018/09/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.